August 30, 2016 5:09 AM ET


Company Overview of Foresight Biotherapeutics, Inc.

Company Overview

Foresight Biotherapeutics, Inc. develops treatments and therapies to address unmet needs in ophthalmology and otolaryngology. Its products include FST-100 for the clinical needs of microbial eradication and reduction in inflammation associated with ocular infections, as well as for adenoviral conjunctivitis; and FST-201, a topical formulation of povidone-iodine and dexamethasone for the treatment of acute otitis media. The company was incorporated in 2008 and is based in New York, New York. As of July 30, 2015, Foresight Biotherapeutics, Inc. operates as a subsidiary of Shire plc.

50 West 57th Street

15th Floor

New York, NY 10019

United States

Founded in 2008





Key Executives for Foresight Biotherapeutics, Inc.

Co-Founder and Director
Age: 43
Co-Founder and Director
Age: 53
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Foresight Biotherapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at